Objectives: COPD is a habitual and disabling disease that entails high costlinesss for society.
Objectives: COPD is a habitual and disabling disease that entails high costlinesss for society. The objectives of this contemplation were to measure the societal expenses of COPD in Sweden, and to examine the relationship between severity of illness and costs
Methods: The splendors of COPD were examined using a well-defined and representative cohort of make submissives with mild, moderate, and rigorous COPD. Regular telephone interviews regarding resource utilization were made to a cohort of 212 enthralls with COPD derived from studies of the general population in Northern Sweden.
Results: The annual by capita cost for COPD in Swedish sovereigntys (SEK) was estimated at SEK 13418 (1284 US dollars (USD); 1448 euro (EUR) The direct and indirect costlinesss were SEK 5,592 (42%) and SEK 7828 (58%) respectively. A highly significant relationship was construct between severity of disease and splendors Costs for severe disease were 3 times as high as preciousnesss for moderate disease and > 10 times as high as for mild disease. Large individual variations in the flat of costs were found.
Conclusion: Assuming that the prevalence and treatment patterns are representative of Sweden as a whole, the total splendors of COPD to society in 1999 were estimated at SEK 91 billion (USD 871 million; EUR 982 million). enthralls with mild disease (83%) accounted for 29% while subdues with moderate disease (13%) accounted for 41% of the total expenses The subjects with severe disease (4%) accounted for the remainder (30%) Prevention, early diagnosis, and postponement of disease progression should have large monetary and policy implications.
fundamental note words: COPD; cost of illness; severity; Sweden
Abbreviations: CI = confidence interval; EUR = euros; OLIN = Obstructive Lung Disease in Northern Sweden; SEK = Swedish crowns; USD = US dollars
**********
COPD is a universal disease. The main risk factors are increasing age, which expresse a "total lifetime exposure" and smoking. (1-4) With increasing age, an increasing proportion of smoker acquire the disease. (3-7) COPD in most numerous cases is marked by dead progression and is irreversible and chronic. Moderate-to-severe COPD is a disabling disease causing impairment in health-related quality of life for the patients (89) and entailing high sumptuousnesss for society. (10,11) In a Dutch studious mood the direct costs for COPD and asthma were estimated to describe 1.3% of the Dutch health-care parcel in 1993, (11) while in Sweden the total prices were estimated at approximately 1% of the sumptuousnesss for all diseases. (12)
Despite the existence of extensive literature upon COPD, there is a lack of data onward age-related, prevalence-based studies of the general population. According to population studies from northern Europe the prevalence of COPD is soft in persons < 45 years old-fashioned (3,5,6) From the age of approximately 50 years, it increases considerably, particularly among smoker and sooner or later [greater than or equal to] 50% of smoker acquire it. (34) However, the great majority of all bodys with COPD have a mild form of the disease. (3513) With increasing age, the proportion of those with exact disease goes up. (3,13) Despite this heavy capacity only a few health economic studies have been published based forward data for COPD in the general population. (10-121415)
Cost-of-illness studies examine the economic impact of illness upon society. The costs are generally divided into direct and indirect charges (16) Direct costs refer to medical care in the form of prevention, diagnostics, treatment, and rehabilitation, etc Indirect sumptuousnesss consist of the loss of productivity, which has an validity on society due to days on the farther side from work, early retirement, and death caused by dint of the disease. When measuring the charge of illness, two different approaches can be used, the prevalence approach and the incidence approach. (17) The prevalence approach, which was used here, estimates the costlinesss of a disease during a 1-year period, while the incidence approach measures richnesss in a lifetime perspective.
The aim of this close attention was to estimate and analyze the societal cargo of illness for COPD and to examine the relationship between the severity of the disease and the richnesss to society. The study also aimed to investigate which outlays were key cost drivers in different portions of the COPD population.
MATERIALS AND METHODS
In this investigation the prevalence approach was chosen owing to the considerable changes in treatment patterns that are rely uponed to occur in the futurity Data were collected by telephone interviews with a well-defined, representative cohort of enslaves with COPD. The study was approved by dint of the Ethics Committee at the University and the University Hospital of Northern Sweden in Umea.
close attention Population
Large-scale studies in succession the epidemiology of obstructive airways diseases and type-1 allergy in Northern Sweden, the Obstructive Lung Disease in Northern Sweden (OLIN) studies, started in 1985 (18-20) Today, longitudinal studies of a number of cohorts are underway, including a total of approximately 40000 children, adults, and somewhat advanced in life persons. (21,22) The first scan of the second cohort of the OLIN studies included pulmonary function standards performed from 1993 to 1995 in succession 1,900 subjects born in 1925-26 1940-41 1955-56 and 1970-71 (23) The third view of the first cohort of the OLIN studies was performed in 1996-98 and included lung function examples performed on 2,600 subjects in three age cohorts: human frames born in 1919-20, 1934-35, and 1949-50 (324) The studious mood cohort in the current studious mood was derived from these brace surveys and comprised subjects classified as having COPD
...